Literature DB >> 21565892

miR-615-3p promotes the phagocytic capacity of splenic macrophages by targeting ligand-dependent nuclear receptor corepressor in cirrhosis-related portal hypertension.

An Jiang1, Shu Zhang, Zongfang Li, Rongrui Liang, Song Ren, Jun Li, Yansong Pu, Jun Yang.   

Abstract

Hypersplenism is a condition in which the spleen is overactive. It is common in patients with cirrhosis-related portal hypertension. The over-activated hemophagocytic splenic macrophages are an important cause of hypersplenism. MicroRNAs (miRNAs) are 21-22 nt single-stranded RNAs expressed endogenously, which play important roles in many diseases. We have found by microarray, previously, that miR-615-3p is highly expressed in splenic macrophages of hypersplenism. In this study, we found that miR-615-3p enhanced the phagocytic capacity of splenic macrophages. Bioinformatics analysis indicated that ligand-dependent nuclear receptor corepressor (LCoR) was a potential phagocytosis-related target of miR-615-3p. This was proved by dual luciferase assay and Western blot in THP-1 cells and normal/hypersplenisum splenic macrophages. Our results showed that the presence of miR-615-3p repressed the expression of LCoR, a derepressor of peroxisome proliferator-activated receptor gamma (PPARγ), which has been confirmed to be able to promote the phagocytic capacity of macrophages. In conclusion, high expression of miR-615-3p in over-activated splenic macrophages depresses LCoR expression, low level of LCoR derepresses the expression of PPARγ and finally upregulated PPARγ enhances the phagocytic capacity of splenic macrophages. This finding might be useful in the study of hypersplenism and other macrophage-associated diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21565892     DOI: 10.1258/ebm.2011.010349

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  20 in total

1.  miR-615-3p expression level in bone marrow is associated with tumor recurrence in hepatocellular carcinoma.

Authors:  Ryota Mukai; Yoshito Tomimaru; Hiroaki Nagano; Hidetoshi Eguchi; Koshi Mimori; Akira Tomokuni; Tadafumi Asaoka; Hiroshi Wada; Koichi Kawamoto; Shigeru Marubashi; Yuichiro Doki; Masaki Mori
Journal:  Mol Clin Oncol       Date:  2015-02-25

Review 2.  miRNAs and estrogen action.

Authors:  Carolyn M Klinge
Journal:  Trends Endocrinol Metab       Date:  2012-04-11       Impact factor: 12.015

3.  Causes of peripheral cytopenia in hepatitic cirrhosis and portal hypertensive splenomegaly.

Authors:  Yunfu Lv; Wan Yee Lau; Hongfei Wu; XiaoYu Han; Xiaoguang Gong; Ning Liu; Jie Yue; Qingqing Li; YeJuan Li; Jie Deng
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-01

Review 4.  Macrophages in Chronic Liver Failure: Diversity, Plasticity and Therapeutic Targeting.

Authors:  Arjuna Singanayagam; Evangelos Triantafyllou
Journal:  Front Immunol       Date:  2021-04-02       Impact factor: 7.561

5.  miR-24, miR-30b, and miR-142-3p regulate phagocytosis in myeloid inflammatory cells.

Authors:  Afsar Raza Naqvi; Jezrom B Fordham; Salvador Nares
Journal:  J Immunol       Date:  2015-01-19       Impact factor: 5.422

Review 6.  MicroRNAs as Regulators of Phagocytosis.

Authors:  Wojciech Gierlikowski; Barbara Gierlikowska
Journal:  Cells       Date:  2022-04-19       Impact factor: 7.666

7.  Urinary exosome miRNome analysis and its applications to salt sensitivity of blood pressure.

Authors:  John J Gildea; Julia M Carlson; Cynthia D Schoeffel; Robert M Carey; Robin A Felder
Journal:  Clin Biochem       Date:  2013-05-29       Impact factor: 3.281

Review 8.  Impact of Nutritional Epigenetics in Essential Hypertension: Targeting microRNAs in the Gut-Liver Axis.

Authors:  Johnathan Kawika Cooper; Rochell Issa; Pratyush Pavan Devarasetty; Rachel M Golonka; Veda Gokula; Joshua Busken; Jasenka Zubcevic; Jennifer Hill; Matam Vijay-Kumar; Bindu Menon; Bina Joe
Journal:  Curr Hypertens Rep       Date:  2021-05-07       Impact factor: 5.369

Review 9.  miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets.

Authors:  Carolyn M Klinge
Journal:  Mol Cell Endocrinol       Date:  2015-02-03       Impact factor: 4.102

10.  Identification of a set of miRNAs differentially expressed in transiently TIA-depleted HeLa cells by genome-wide profiling.

Authors:  Carmen Sánchez-Jiménez; Isabel Carrascoso; Juan Barrero; José M Izquierdo
Journal:  BMC Mol Biol       Date:  2013-02-06       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.